Breaks Categories: News

MondayFeb 10, 2020 1:36 pm

NetworkNewsBreaks – InvestorBrandNetwork and NetworkNewsWire to Leverage Expertise, Communication Solutions and Provide On-Site Coverage for Emerging Growth Spring Invitational

NetworkNewsWire (“NNW”), a multifaceted financial news and publishing company part of the InvestorBrandNetwork (“IBN”), today announced that it will serve as the official newswire for the upcoming Emerging Growth Spring Invitational. IBN, as the official media sponsor of the conference, will contribute additional social media distribution via its 40+ investor-oriented brands. The event, hosted by Veyo Partners and Diamond Equity Research, is slated to take place at the Cornell Club in New York City on March 26, 2020. “We are pleased to be part of the invitational taking place next month. In addition to leveraging our expertise and communication solutions…

Continue Reading

MondayFeb 10, 2020 1:09 pm

NetworkNewsBreaks – Talos Energy, Inc. (NYSE: TALO) Featured in ROTH Equity Research Report

Talos Energy (NYSE: TALO) was featured in a recent Equity Research Report published by ROTH Capital Partners, LLC. The report reads, “TALO announced an operations update and the filing of a preliminary Schedule 14C information statement with the SEC, as a step towards closing of the previously announced acquisition of affiliates of ILX Holdings (private).” To request access to the full report, visit http://nnw.fm/DXCr3 About Talos Energy Talos Energy (NYSE: TALO) is a technically driven independent exploration and production company focused on safely and efficiently maximizing cash-flows and long-term value through its operations, currently in the United States Gulf of…

Continue Reading

MondayFeb 10, 2020 12:52 pm

NetworkNewsBreaks – Eastside Distilling, Inc. (NASDAQ: EAST) Featured in ROTH Equity Research Report

Eastside Distilling (NASDAQ: EAST) was featured in a recent Equity Research Report published by ROTH Capital Partners, LLC. The report reads, “Last night, EAST provided preliminary year-end financial results with branded case volumes largely in-line, offset by relatively soft canning results. Certain Redneck demand was also proactively moved to 1Q20 to increase case profitability. EAST's forward update was encouraging, anchored by Redneck's newest national win, 740 Rite Aid stores, and a CY20 focus on widening its national platform for its Azunia, Burnside and Hue-Hue brands. EAST also called for 4Q20 EBITDA profitability, two quarters ahead of our previous projection. Maintain…

Continue Reading

MondayFeb 10, 2020 12:36 pm

NetworkNewsBreaks – Identiv, Inc. (NASDAQ: INVE) Featured in ROTH Equity Research Report

Identiv (NASDAQ: INVE) was featured in a recent Equity Research Report published by ROTH Capital Partners, LLC. The report reads, “Identiv announced preliminary 4Q19 revenue well below expectations. It expects revenue of $18.7-$18.8 million with a gross profit margin (gpm) of approximately 39%, resulting in a net loss of $2.2 million to $2.1 million or ($0.14) to ($0.13) per share to the company after adding back $265,000 preferred stock dividend. Adjusted EBITDA guidance was 0-$100,000 or $6.6$6.7 million for the year.” To request access to the full report, visit http://nnw.fm/DXCr3 About Identiv Identiv, Inc. is a global provider of physical…

Continue Reading

MondayFeb 10, 2020 11:36 am

NetworkNewsBreaks – Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) Featured in Mizuho Securities Research Report

Aerie Pharmaceuticals (NASDAQ: AERI) was featured in a recent U.S. Equity Research Report published by Mizuho Securities USA LLC. The report reads, “We are including IQVIA scripts for Rhopressa and Rocklatan below for the week ended 1/31/2020. Please note that these numbers were affected by the holiday on 1/20/2020, as expected. Franchise TRx was +0.8% to 10,076 from 9,996 the prior week; franchise NRx was -0.4% to 4,257 from 4,272 the prior week. Rocklatan TRx was 2,912 in Week 41, compared to 2,932 in Week 40.” To request access to the full report, visit http://nnw.fm/SaZ9d About Aerie Pharmaceuticals, Inc. Aerie…

Continue Reading

MondayFeb 10, 2020 11:35 am

NetworkNewsBreaks – GP Solutions, Inc. (GWPD) Featured in iGrow News Article that Describes Capabilities of Controlled Environment Micro-Farms to Produce Food That Is “Better Than Organic”

GP Solutions (OTC: GWPD), the developer of "GrowPods" – controlled environment automated micro-farms, today announced that it was featured in an iGrow News article that indicates new Controlled Environment Micro-Farms, such as GrowPods, produce food that is "better than organic." According to the publication, huge misconceptions surround organic food. Organic farms can use certain pesticides, despite popular belief, and the labeling of organic food items can cause confusion because some may contain only a percentage of organic ingredients. The article reads, "Controlled Environment Micro-Farms allow growers to cultivate fruits, herbs, and vegetables in a sealed environment that virtually eliminates the…

Continue Reading

MondayFeb 10, 2020 10:59 am

NetworkNewsBreaks – Xeris Pharmaceuticals, Inc. (NASDAQ: XERS) Featured in Mizuho Securities Research Report

Xeris Pharmaceuticals (NASDAQ: XERS) was featured in a recent U.S. Equity Research Report published by Mizuho Securities USA LLC. The report reads, “We are including IQVIA scripts for Gvoke and glucagon below for the week ended 1/31/2020. Please note that these numbers were affected by the holiday on 1/20/2020 as expected. Gvoke TRx was +8.0% to 230 from 213 the prior week; Gvoke NRx was +7.2% to 222 from 207 the prior week. Total Glucagon TRx was 12,771, +16.2% y/y; total Glucagon NRx was +17.7% y/y to 10,245.” To request access to the full report, visit http://nnw.fm/SaZ9d About Xeris Pharmaceuticals,…

Continue Reading

MondayFeb 10, 2020 10:33 am

NetworkNewsBreaks – Crexendo, Inc. (CXDO) Named to 2020 OTCQX Best 50

Crexendo (OTCQX:CXDO), an award-winning premier provider of cloud communications, UCaaS (Unified Communications as a Service), call center, collaboration services, and other cloud business services that are designed to provide enterprise-class cloud services to any size business at affordable monthly rates, today announced it has been named to the 2020 OTCQX(R) Best 50. An annual ranking of the top 50 U.S. and international companies traded on the OTCQX market, the OTCQX Best 50 is calculated based on an equal weighting of one-year total return and average daily dollar volume growth in the previous calendar year. Companies in the 2020 OTCQX Best…

Continue Reading

MondayFeb 10, 2020 10:09 am

NetworkNewsBreaks – Nightfood Holdings Inc. (NGTF) Eyes Tremendous New Market Segment as Pregnancy Care Providers Begin Recommending Nightfood to Expecting Moms

Nightfood Holdings (OTCQB: NGTF), the award-winning ice cream company addressing America’s $50 billion-dollar nighttime snacking problem, today announced that pregnancy care providers have begun recommending Nightfood to their pregnant clients, and the Company intends to aggressively pursue and serve this valuable market segment. With a well-documented link between pregnancy and ice cream cravings, pregnant women have specific nutritional needs that happen to correlate with the unique benefits of Nightfood’s formulation. These include extra calcium, magnesium, zinc, fiber, and protein, which are all recommended, while sugars should be kept down. Nightfood also has ingredients to minimize heartburn, which can be a…

Continue Reading

MondayFeb 10, 2020 9:39 am

NetworkNewsBreaks – Endonovo Therapeutics, Inc. (ENDV) Collaborates with Major Universities for the Evaluation of SofPulse(R) for Orthopedic Surgeries

Endonovo Therapeutics (OTCQB: ENDV) today announced the evaluation of its SofPulse(R) device at major universities for orthopedic surgeries. Endonovo’s FDA-Cleared SofPulse(R) is a non-invasive device utilized for the reduction of postoperative pain and edema and represents a low-cost drug-free solution for reducing opioid usage, accelerating patient recovery and preventing opioid addiction following surgical procedures. “We are pleased to announce SofPulse(R) is now being evaluated at major medical universities. We believe this is a unique opportunity for SofPulse(R) to be evaluated, and upon completion and approval, be used as a standard of healthcare moving forward,” Endonovo Therapeutics CEO Alan Collier said…

Continue Reading